Literature DB >> 28845848

Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Leigh V Panlilio1, Zuzana Justinova1.   

Abstract

Cannabis use has become increasingly accepted socially and legally, for both recreational and medicinal purposes. Without reliable information about the effects of cannabis, people cannot make informed decisions regarding its use. Like alcohol and tobacco, cannabis can have serious adverse effects on health, and some people have difficulty discontinuing their use of the drug. Many cannabis users progress to using and becoming addicted to other drugs, but the reasons for this progression are unclear. The natural cannabinoid system of the brain is complex and involved in many functions, including brain development, reward, emotion, and cognition. Animal research provides an objective and controlled means of obtaining information about: (1) how cannabis affects the brain and behavior, (2) whether medications can be developed to treat cannabis use disorder, and (3) whether cannabis might produce lasting changes in the brain that increase the likelihood of becoming addicted to other drugs. This review explains the tactics used to address these issues, evaluates the progress that has been made, and offers some directions for future research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28845848      PMCID: PMC5719102          DOI: 10.1038/npp.2017.193

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  251 in total

1.  Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion.

Authors:  M López-Gallardo; A B López-Rodríguez; Á Llorente-Berzal; D Rotllant; K Mackie; A Armario; R Nadal; M-P Viveros
Journal:  Neuroscience       Date:  2011-10-06       Impact factor: 3.590

Review 2.  Review. The incentive sensitization theory of addiction: some current issues.

Authors:  Terry E Robinson; Kent C Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

3.  Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice.

Authors:  William S Hyatt; William E Fantegrossi
Journal:  Behav Pharmacol       Date:  2014-06       Impact factor: 2.293

Review 4.  Constitutive activity in cannabinoid receptors.

Authors:  Tung M Fong
Journal:  Adv Pharmacol       Date:  2014

5.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice.

Authors:  E Valjent; R Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2000-01       Impact factor: 4.530

7.  Part II: Strain- and sex-specific effects of adolescent exposure to THC on adult brain and behaviour: Variants of learning, anxiety and volumetric estimates.

Authors:  R J Keeley; J Trow; C Bye; R J McDonald
Journal:  Behav Brain Res       Date:  2015-01-12       Impact factor: 3.332

8.  Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.

Authors:  X Wu; E D French
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

9.  The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.

Authors:  Zuzana Justinova; Gianluigi Tanda; Patrik Munzar; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

10.  Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series.

Authors:  Jose M Trigo; Alexandra Soliman; Gregory Staios; Lena Quilty; Benedikt Fischer; Tony P George; Jürgen Rehm; Peter Selby; Allan J Barnes; Marilyn A Huestis; Bernard Le Foll
Journal:  J Addict Med       Date:  2016 Jul-Aug       Impact factor: 3.702

View more
  13 in total

1.  Cannabis and Cannabinoids: From Synapse to Society.

Authors:  Margaret Haney; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2018-01       Impact factor: 7.853

2.  Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Authors:  Catherine Orr; Philip Spechler; Zhipeng Cao; Matthew Albaugh; Bader Chaarani; Scott Mackey; Deepak D'Souza; Nicholas Allgaier; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Büchel; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Vincent Frouin; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Rajiv Radhakrishnan; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan
Journal:  J Neurosci       Date:  2019-01-14       Impact factor: 6.167

3.  Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Authors:  Daniel G Barrus; Timothy W Lefever; Jenny L Wiley
Journal:  Neuropharmacology       Date:  2018-05-03       Impact factor: 5.250

Review 4.  Adverse Effects of Recreational and Medical Cannabis.

Authors:  Ivan Urits; Karina Charipova; Kyle Gress; Nathan Li; Amnon A Berger; Elyse M Cornett; Hisham Kassem; Anh L Ngo; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2021-01-12

5.  Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli.

Authors:  Cora E Smiley; Heyam K Saleh; Katherine E Nimchuk; Constanza Garcia-Keller; Justin T Gass
Journal:  Behav Brain Res       Date:  2021-08-10       Impact factor: 3.352

Review 6.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

Review 7.  The changing opioid crisis: development, challenges and opportunities.

Authors:  Nora D Volkow; Carlos Blanco
Journal:  Mol Psychiatry       Date:  2020-02-04       Impact factor: 15.992

Review 8.  Cannabinoid disruption of learning mechanisms involved in reward processing.

Authors:  Carl R Lupica; Alexander F Hoffman
Journal:  Learn Mem       Date:  2018-08-16       Impact factor: 2.460

9.  Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis.

Authors:  Eduardo R Butelman; Angelo G I Maremmani; Silvia Bacciardi; Carina Y Chen; Joel Correa da Rosa; Mary Jeanne Kreek
Journal:  Front Psychiatry       Date:  2018-06-27       Impact factor: 4.157

10.  Endocannabinoid genetic variation enhances vulnerability to THC reward in adolescent female mice.

Authors:  Caitlin E Burgdorf; Deqiang Jing; Ruirong Yang; Chienchun Huang; Matthew N Hill; Ken Mackie; Teresa A Milner; Virginia M Pickel; Francis S Lee; Anjali M Rajadhyaksha
Journal:  Sci Adv       Date:  2020-02-12       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.